SynBioBeta Speaker
Marc Tessier-Lavigne
Chairman & CEO
Xaira
May 2026, SynBioBeta
Speaker
Marc Tessier-Lavigne is co-founder, Chairman & CEO of Xaira Therapeutics. Previously, he held executive positions in the private sector at Genentech, where he was executive vice president for research and chief scientific officer, and in the academic sector, where he served as president of The Rockefeller University and then of Stanford University, where he remains professor of Biology (on leave). He also served previously on the faculty of the University of California, San Francisco, and was an investigator with the Howard Hughes Medical Institute. A Rhodes Scholar, Dr. Tessier-Lavigne has been a leader in understanding mechanisms that direct the wiring of the brain, and has helped elucidate mechanisms of neurodegeneration. He is the recipient of numerous scientific awards, including the 2020 Gruber Neuroscience Prize, and has been elected to multiple scientific societies, including the US National Academy of Sciences and US National Academy of Medicine; he is also an Officer of the Order of Canada, one of that country’s highest honors. Dr. Tessier-Lavigne has co-founded two neuroscience startups, Renovis and Denali, and served on the boards of Agios, Regeneron, Pfizer, Juno and Denali.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
04:13:04:45
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.